Moderna Wants Claims In COVID-19 Vax Patent Suit Tossed

By Dave Simpson · May 23, 2022, 10:56 PM EDT

Moderna Inc. urged a Delaware federal court to nix several claims from an infringement suit claiming it used technology Alnylam Pharmaceuticals Inc. developed that ensures the mRNA in COVID-19 vaccines safely...

To view the full article, register now.

Documents

Case Information

Case Title

Alnylam Pharmaceuticals, Inc. v. Moderna, Inc., et al

Case Number

1:22-cv-00335

Court

Delaware

Nature of Suit

Patent

Date Filed

March 17, 2022


Case Title

Alnylam Pharmaceuticals, Inc. v. Pfizer Inc., et al

Case Number

1:22-cv-00336

Court

Delaware

Nature of Suit

Patent

Date Filed

March 17, 2022